☆ 4.7 Article

SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways

JOURNAL OF MEDICAL VIROLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Virology

SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways

Jian Deng et al.

Summary: The NSP7 protein of SARS-CoV-2 inhibits the production of interferons, crucial components of antiviral immunity, by targeting multiple signaling pathways. It disrupts the normal functioning of RIG-I/MDA5, TLR3-TRIF, and cGAS-STING pathways, leading to a dampened interferon response. Additionally, NSP7 decreases immune activation and facilitates virus replication.

JOURNAL OF MEDICAL VIROLOGY (2023)

Add to Collection

Article Immunology

SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy

Xingyu Li et al.

Summary: The study reveals a novel mechanism by which ORF10 of SARS-CoV-2 inhibits the innate immune response through inducing mitophagy-mediated MAVS degradation.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Add to Collection

Review Virology

Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19

Moumita Manik et al.

Summary: TLRs are crucial regulators of the immune system, helping to differentiate between self and nonself molecules. Imbalance can lead to over-transcription and translation of inflammatory genes, releasing inflammatory molecules and causing a cytokine storm, ultimately resulting in multiple organ failure and death.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

The cGAS-STING pathway drives type I IFN immunopathology in COVID-19

Jeremy Di Domizio et al.

Summary: This study reveals the mechanism behind aberrant type I interferon responses in COVID-19 through the cGAS-STING pathway and demonstrates its importance in severe cases. By using animal and lung-on-chip models, the study provides insights into host-directed therapeutic strategies for COVID-19.

NATURE (2022)

Add to Collection

Review Immunology

Innate immunity: the first line of defense against SARS-CoV-2

Michael S. Diamond et al.

Summary: Kanneganti and Diamond review the crucial role of innate immunity in controlling and immunopathology of COVID-19. They discuss how the innate immune system detects and responds to SARS-CoV-2, which can help identify targeted therapeutic approaches to mitigate severe diseases and improve patient outcomes.

NATURE IMMUNOLOGY (2022)

Add to Collection

Review Virology

The role of type I interferon in the treatment of COVID-19

Fatemeh Sodeifian et al.

Summary: Research has shown that IFNs have a protective effect against SARS-CoV-2 in the early stages, but may cause immunopathology and long-lasting harm in the severe inflammatory phase. Therefore, it is crucial to determine the optimal timing for IFN administration.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Mechanisms of Antiviral Immune Evasion of SARS-CoV-2

Daniel Beyer et al.

Summary: This article summarizes the mechanisms by which SARS-CoV-2 antagonizes interferon production and signaling to establish productive infection. Understanding host-pathogen interactions is critical for managing COVID-19.

JOURNAL OF MOLECULAR BIOLOGY (2022)

Add to Collection

Review Immunology

Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection

Carolina Chiale et al.

Summary: Recent research has revealed the important protective role of interferons (IFNs) against COVID-19, with human deficiencies in IFN responses serving as predictors of disease severity. The mechanisms by which SARS-CoV-2 evades IFN responses and the ongoing efforts to implement IFNs as therapeutics for COVID-19 are also discussed. Understanding the relationship between SARS-CoV-2 and IFN is crucial for informing treatments that exploit IFN functions to mitigate COVID-19.

IMMUNOLOGICAL REVIEWS (2022)

Add to Collection

Article Virology

SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy

Lulu Han et al.

Summary: A characteristic feature of COVID-19 is the dysregulated immune response and overwhelming inflammatory cytokine storm. This study demonstrates that the ORF10 protein of SARS-CoV-2 interacts with STING, impairing the cGAS-STING signaling pathway and weakening the innate antiviral immunity.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation

Zhang Xu et al.

Summary: This study discovers a mechanism by which the SARS-CoV-2 virus suppresses the production of IFN-beta by coopting cellular machinery, and identifies the roles of GIGYF2 and 4EHP in this process.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Biochemistry & Molecular Biology

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity

Yuehui Zhang et al.

Summary: The study systematically investigates the interactions between 29 viral proteins and human cells, revealing key proteins involved in SARS-CoV-2 infection. It identifies the membrane protein ITGB1 as a mediator of viral entry and uncovers proteins that inhibit the interferon pathway. The research proposes potential drugs for COVID-19 treatment and provides valuable insights into viral infection mechanisms.

CELL CHEMICAL BIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules

Yi Zheng et al.

Summary: This study reveals the involvement of the stress response pathway and innate antiviral immunity in the pathogenic mechanism of SARS-CoV-2. NSP5 and N protein of SARS-CoV-2 were found to attenuate the formation of antiviral stress granules (avSG). NSP5 suppressed avSG formation and disrupted the RIG-I-MAVS complex to weaken the RIG-I-mediated antiviral response, while N protein specifically targeted cofactors upstream of RIG-I and affected the recognition of dsRNA by RIG-I.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Add to Collection

Article Virology

Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure

Shamlan M. S. Reshamwala et al.

Summary: Specific mutations in nsp7 and nsp8 proteins identified in viral genomes may play a role in stabilizing the replication/transcription complex by affecting the formation of the RdRp-nsp7-nsp8 supercomplex.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Immunology

SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species

Mehdi Moustaqil et al.

Summary: The study revealed that the proteases NSP3 and NSP5 of SARS-CoV-2 can cleave proteins involved in host immune responses, shedding light on the mechanisms behind enhanced inflammatory responses in COVID-19 patients. The direct cleavage of specific proteins by these proteases provides insights into the pathophysiology of the disease.

EMERGING MICROBES & INFECTIONS (2021)

Add to Collection

Article Immunology

SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation

Wenjing Wang et al.

Summary: The study found that SARS-CoV-2 nsp12 suppresses host antiviral responses by attenuating specific IFN promoter activation and impacting the function of IRF3. These findings provide new insights into the viral pathogenesis.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Review Virology

Role of Toll-like receptors in the pathogenesis of COVID-19

Shaghayegh Khanmohammadi et al.

Summary: COVID-19 caused by SARS-CoV-2 has led to a pandemic. TLRs play a crucial role in activating the immune system in response to the virus, and could potentially be a target for controlling the infection. Understanding the mechanisms of TLR in COVID-19 may help in developing vaccines and treatments.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Replication and single-cycle delivery of SARS-CoV-2 replicons

Inna Ricardo-Lax et al.

Summary: Molecular virology tools are crucial for studying SARS-CoV-2 and developing therapeutics. A yeast-based reverse genetics system was used to create spike-deleted self-replicating RNAs for SARS-CoV-2. These noninfectious replicons can be complemented with viral glycoproteins for single-cycle delivery into different cell types, making it a versatile platform for antiviral drug screening and viral variant characterization.

SCIENCE (2021)

Add to Collection

Article Cell Biology

SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO

Jing Wu et al.

Summary: SARS-CoV-2 activates and represses the innate immune response, leading to dysregulation and delayed interferon expression, which contribute to the development of COVID-19. The study reveals that ORF9b inhibits the type I interferon response during SARS-CoV-2 infection.

CELL REPORTS (2021)

Add to Collection

Article Microbiology

A novel cell culture system modeling the SARS-CoV-2 life cycle

Xiaohui Ju et al.

Summary: A BSL-2 cell culture system for production of replication-competent SARS-CoV-2 virus-like-particles was developed. This system allows for the complete viral life cycle to be achieved and enhances biosafety measures. High-throughput antiviral screening was conducted, leading to the discovery of new drugs against SARS-CoV-2 infection.

PLOS PATHOGENS (2021)

Add to Collection

Article Multidisciplinary Sciences

TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection

Yongjian Wu et al.

Summary: Limited understanding of T cell responses against SARS-CoV-2 has hindered vaccine development and drug discovery for COVID-19. This study reveals an previously unknown role for TREM-2 in SARS-CoV-2 infection, suggesting potential strategies for drug discovery and clinical management of COVID-19.

SCIENCE ADVANCES (2021)

Add to Collection

Article Virology

SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways

Lulu Han et al.

Summary: The SARS-CoV-2 ORF9b protein inhibits the production of type I and type III interferons by targeting multiple molecules of innate antiviral signaling pathways, thus facilitating viral replication.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis

Yaara Finkel et al.

Summary: The study reveals that SARS-CoV-2 infection leads to a global reduction in translation and accelerated degradation of cytosolic cellular mRNAs. It also impairs the translation of transcripts induced in response to infection, probably mediated by inhibition of nuclear mRNA export.

NATURE (2021)

Add to Collection

Article Cell Biology

Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities

Manuel Hayn et al.

Summary: SARS-CoV-2 proteins synergize to counteract innate immune responses, but they are vulnerable to type II and III interferons. Experimental results show potent inhibition of SARS-CoV-2 infection by interferon-gamma and lambda 1, highlighting potential for effective antiviral approaches.

CELL REPORTS (2021)

Add to Collection

Article Microbiology

ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity

GuanQun Liu et al.

Summary: Conjugation of ISG15 plays a crucial role in activating the RIG-I-like receptor MDA5 and triggering antiviral responses, while SARS-CoV-2 suppresses MDA5 activation through direct de-ISGylation to evade innate immunity.

NATURE MICROBIOLOGY (2021)

Add to Collection

Article Virology

A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery

Yun-Yun Jin et al.

Summary: This study successfully constructed a non-infectious SARS-CoV-2 replicon system, and found that RNA polymerase, exonuclease, and cap N7 methyltransferase play essential roles in genome replication and subgenome RNA production through mutational analysis of nsp12 and nsp14. Additionally, a SARS-CoV-2 replicon carrying a luciferase reporter gene was validated in inhibition assays with known anti-SARS-CoV-2 inhibitors, indicating that this one-plasmid system is both biosafe and convenient for use in fundamental research and antiviral drug development.

VIROLOGICA SINICA (2021)

Add to Collection

Review Virology

Interferon-alpha position in combating with COVID-19: A systematic review

Ailar Nakhlband et al.

Summary: IFN-alpha may have potential advantages in treating COVID-19, as the study results show that it can reduce the time for virus clearance and hospitalization, making it a promising treatment option.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms

Christine Vazquez et al.

Summary: The SARS-CoV-2 virus blocks interferon signaling and reduces activation of NF-kappa B through distinct mechanisms, bypassing multiple innate immune activation pathways.

PLOS ONE (2021)

Add to Collection

Article Microbiology

SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response

Yongzhen Liu et al.

Summary: The study reveals the innate immune evasion strategy of SARS-CoV-2 mediated by the Nsp5 main protease and the development of a small-molecule inhibitor, which restores the innate immune response and inhibits viral replication. These findings provide potential antiviral agents for treating COVID-19 patients.

MBIO (2021)

Add to Collection

Article Microbiology

SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon

Maya Shemesh et al.

Summary: Type I interferons play a crucial role in combating viral infections, yet SARS-CoV-2 virus has evolved to disrupt immune defenses by blocking IFN beta production through six genes. Despite reducing pSTAT1 levels, the virus still activates antiviral programs and remains sensitive to added interferon, presenting a therapeutic opportunity.

PLOS PATHOGENS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection

Zhuo Zhou et al.

Summary: SARS-CoV-2 infection activates the host innate immune response through cytoplasmic DNA sensing pathway, involving cGAS and STING. Research shows that chromatin DNA can be transferred from the nucleus to the cytoplasm upon infection, triggering an immune alarm response. The study also highlights the essential roles of cGAS and STING in combating SARS-CoV-2, with potential therapeutic implications.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins

Yajuan Rui et al.

Summary: The study identified SARS-CoV-2 structural proteins, accessory proteins, and the main viral protease as potent inhibitors of host innate immune responses of distinct pathways. Main viral protease was found to inhibit both the RLR and cGAS-STING pathways, while ORF3a had the unique ability to inhibit STING and structural protein N was a unique RLR inhibitor.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Immunology

SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response

Yu-Zhi Fu et al.

Summary: A novel SARS-related coronavirus (SARS-CoV-2) has emerged as a serious pathogen causing high morbidity and mortality. The membrane glycoprotein M of SARS-CoV-2 was identified as a negative regulator of the innate immune response by impairing MAVS aggregation and downstream signaling, thus evading the innate antiviral response.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Review Virology

Coronavirus infections and immune responses

Geng Li et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Review Virology

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Yu Chen et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Roujian Lu et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

The Architecture of SARS-CoV-2 Transcriptome

Dongwan Kim et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

Donghyuk Shin et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jerome Hadjadj et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Activation and evasion of type I interferon responses by SARS-CoV-2

Xiaobo Lei et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Virology

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway

Jin-Yan Li et al.

VIRUS RESEARCH (2020)

Add to Collection

Article Cell Biology

Evasion of Type I Interferon by SARS-CoV-2

Hongjie Xia et al.

CELL REPORTS (2020)

Add to Collection

Article Cell Biology

SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant

Yoriyuki Konno et al.

CELL REPORTS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling

Yi Zheng et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Letter Biochemistry & Molecular Biology

A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins

Jing Zhang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Letter Biochemistry & Molecular Biology

Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling

Yaoxing Wu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Immunology

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

Chun-Kit Yuen et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation

Siqi Liu et al.

SCIENCE (2015)

Add to Collection

© Peeref 2019-2024. All rights reserved.